Epidermal Growth Factor (EGF) Ligand Release by Substrate-specific A Disintegrin and Metalloproteases (ADAMs) Involves Different Protein Kinase C (PKC) Isoenzymes Depending on the Stimulus

被引:36
|
作者
Dang, Michelle [1 ,2 ]
Dubbin, Karen [1 ,3 ]
D'Aiello, Antonio [1 ,4 ]
Hartmann, Monika [5 ]
Lodish, Harvey [1 ,2 ]
Herrlich, Andreas [1 ,4 ]
机构
[1] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
[2] MIT, Dept Biol, Cambridge, MA 02142 USA
[3] MIT, Dept Mat Sci, Cambridge, MA 02142 USA
[4] Harvard Univ, Sch Med, Brigham & Womens Hosp, Renal Unit, Boston, MA 02114 USA
[5] Fritz Lipman Inst Age Res, D-07745 Jena, Germany
基金
美国国家卫生研究院;
关键词
NECROSIS-FACTOR-ALPHA; INTRACELLULAR MATURATION; L-SELECTIN; HB-EGF; RECEPTOR; TRANSACTIVATION; CLEAVAGE; LOCALIZATION; COMPONENTS; CLONING;
D O I
10.1074/jbc.M110.187823
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The dysregulation of EGF family ligand cleavage has severe consequences for the developing as well as the adult organism. Therefore, their production is highly regulated. The limiting step is the ectodomain cleavage of membrane-bound precursors by one of several a disintegrin and metalloprotease (ADAM) metalloproteases, and understanding the regulation of cleavage is an important goal of current research. We have previously reported that in mouse lung epithelial cells, the pro-EGF ligands TGF alpha, neuregulin 1 beta (NRG), and heparin-binding EGF are differentially cleaved depending on the cleavage stimulus (Herrlich, A., Klinman, E., Fu, J., Sadegh, C., and Lodish, H. (2008) FASEB J.). In this study in mouse embryonic fibroblasts that lack different ADAMs, we show that induced cleavage of EGF ligands can involve the same substrate-specific metalloprotease but does require different stimulus-dependent signaling pathways. Cleavage was stimulated by phorbol ester (12-O-tetradecanoylphorbol-13-acetate (TPA), a mimic of diacylglycerol and PKC activator), hypertonic stress, lysophosphatidic acid (LPA)-induced G protein-coupled receptor activation, or by ionomycin-induced intracellular calcium release. Although ADAMs showed substrate preference (ADAM17, TGF alpha and heparin-binding EGF; and ADAM9, NRG), substrate cleavage differed substantially with the stimulus, and cleavage of the same substrate depended on the presence of different, sometimes multiple, PKC isoforms. For instance, classical PKC was required for TPA-induced but not hypertonic stress-induced cleavage of all EGF family ligands. Inhibition of PKC zeta enhanced NRG release upon TPA stimulation, but it blocked NRG release in response to hypertonic stress. Our results suggest a model in which substantial regulation of ectodomain cleavage occurs not only on the metalloprotease level but also on the level of the substrate or of a third protein.
引用
收藏
页码:17704 / 17713
页数:10
相关论文
共 4 条
  • [1] Activated Protein Kinase C (PKC) Is Persistently Trafficked with Epidermal Growth Factor (EGF) Receptor
    Heckman, Carol A.
    Biswas, Tania
    Dimick, Douglas M.
    Cayer, Marilyn L.
    BIOMOLECULES, 2020, 10 (09) : 1 - 17
  • [2] cGMP inhibition of mitogen activated protein kinase (MAPK) and protein kinase C (PKC) blunts angiotensin-II (ANG-II) and epidermal growth factor (EGF) stimulation of c-phospholipase A(2) (cPLA(2))
    Barnett, RL
    Hakker, I
    Pasmantier, R
    Josepovitz, C
    Nord, EP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2114 - A2114
  • [3] Activation of Cytosolic Phospholipase A2α by Epidermal Growth Factor (EGF) and Phorbol Ester in HeLa Cells: Different Effects of Inhibitors for EGF Receptor, Protein Kinase C, Src, and C-Raf
    Matsuzawa, Yasuo
    Kiuchi, Yoshiaki
    Toyomura, Kaori
    Matsumoto, Ikiru
    Nakamura, Hiroyuki
    Fujino, Hiromichi
    Murayama, Toshihiko
    Kawashima, Tatsuo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 111 (02) : 182 - 192
  • [4] Regulation of ornithine decarboxylase (ODC) expression in human glioblastoma cell lines involves through distinct protein kinase C (PKC)- and epidermal growth factor receptor (EGFR)-mediated mechanisms.
    da Rocha, AB
    Mans, DRA
    Lenz, G
    Fernandes, K
    de Lima, C
    Gonçalves, D
    Ruschel, C
    Schwartsmann, G
    CLINICAL CANCER RESEARCH, 1999, 5 : 3802S - 3802S